Shruti Jolly: Treating lung cancer with immunotherapy and radiation without chemotherapy
Shruti Jolly, Associate Director for the Statewide Cancer Network at Michigan Medicine, shared on LinkedIn:
“Treating lung cancer with immunotherapy and radiation without chemotherapy – this new research included our patients from the University of Michigan Radiation Oncology, Montefiore Einstein Comprehensive Cancer Center, and others.
The study published in JCO led by Nitin Ohri in suggests Pembrolizumab and risk-adapted radiotherapy, without chemotherapy, offer promising results for patients with advanced non-small-cell lung cancer (LA-NSCLC) and a PD-L1 TPS of ≥50%. The 1-year survival rate was high at 76% with minimal adverse events.
An inspiring step towards more effective, tolerable cancer treatments!”
For the article click here.
Source: Shruti Jolly/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023